Tuberculosis (TB) is an infectious disease caused by Mycobacterium
tuberculosis (MTB), which has been recognised as the main reason
leading to single-infection source-related death in the world.[1] However, the precise aetiology and pathogenesis of TB is still uncertain. TB
progresses for numerous reasons such as environmental factors and a variety of other
risk factors, including malnutrition, infection by HIV, immune depressive therapy
and diabetes mellitus.[2] While there are an estimated two billion cases of MTB, only 5–10% of these
patients will progress to active disease,[3] indicating the potentially crucial role of host genetic factors in the
susceptibility to TB.Cytokines are important for host susceptibility and TB progression. IL-18 is one of
the IL-1 family members, which represents a vital pro-inflammatory cytokine with a
crucial role in the inflammatory cascade.[4] IL-18 is released by various cells, including monocytes, activated
macrophages and Kupffer cells.[5] High serum IL-18 levels are also detected in TB patients.[6] Prior research supports that IL-18 may exert a crucial role against MTBinfection in the host, as well as immunity to TB.[7]The IL-18 gene, located on chromosome 11q22.2–q22.3, consists of six exons and five introns.[8] Numerous polymorphisms in the IL-18 gene promoter region have also been
reported. In recent years, attention has been paid to such polymorphisms, especially
the -137C/G(rs187238) and -607A/C(rs1946518) polymorphisms of the IL-18 gene
promoter. It has been recognised that IL-18 polymorphisms of the IL-18 gene promoter
are correlated with numerous disorders, including asthma,[9] type 1 diabetes[10] and viral diseases.[11]Many studies have examined the relationship between IL-18 polymorphisms and
susceptibility to TB. Nonetheless, no consistent conclusions have been reached, and
single research may be of less capable of determining combined effects. Moreover,
some research is restricted further due to the sample size, thereby being less
powerful in examining potential effects. The current meta-analysis was therefore
carried out by combining qualified studies to assess the genetic influences of IL-18-137C/G and -607A/C polymorphisms on susceptibility to TB.
Materials and methods
Literature search and inclusion criteria
Electronic databases, including PubMed, EMBASE, Web of Science, Google Scholar
and the Chinese National Knowledge Infrastructure (CNKI), were systemically
searched from inception to 1 February 2019 in accordance with Preferred
Reporting Items for Systematic Reviews and Meta-Analyses framework, with no
restrictions of language, time period or sample size. The keywords ‘interleukin
18/IL 18’, ‘-137C/G’, ‘-607A/C’, ‘tuberculosis’ and ‘polymorphism’ were used in
the searches. Furthermore, a manual search was carried out on the references
listed in each retrieved item, so that no relevant papers were missed.
Criteria for inclusion and exclusion
The inclusion criteria of papers used in the current meta-analysis were: (a)
relevant case-control study of TB cases and normal subjects, (b) articles
investigating the relationships between IL-18-137C/G and -607A/C polymorphisms
and susceptibility to TB and (c) research containing sufficient genotype
information. Exclusion criteria were: (a) non-case-control studies; (b) case
reports, reviews or meta-analyses; and (c) studies with insufficient original
data.
Information extraction
The following information was collected: the surname of the first author, the
publication date, country, ethnicity, numbers of cases and controls, the
genotype frequencies of IL-18 polymorphisms and deviation from the
Hardy–Weinberg equilibrium (HWE) in the control group.
Statistical analysis
First, the HWE test was performed on all individual studies in the control group
using the chi-square test. Subsequently, the relationships between IL-18-137C/G
and -607A/C polymorphisms and TB susceptibility were estimated by calculating
the combined odds ratio (OR), as well as the related 95% confidence intervals
(CIs). Meanwhile, potential heterogeneities among the enrolled studies were
examined using the I2 test. Typically, an
I2 of > 50% suggests the presence of
heterogeneity in an enrolled study. So, the random-effects model was adopted in
this meta-analysis. Furthermore, subgroup analysis stratified by HWE was also
carried out. To assess result stability, a sensitivity test was also conducted
by excluding one study at a time from the combined analysis in order to
determine the impact of each study on the overall ORs. Finally, publication bias
was assessed through funnel plot analysis. The meta package of R v3.33 (R
Foundation for Statistical Computing, Vienna, Austria) was used in this
meta-analysis.
Results
Characteristics of included studies
As shown in Figure 1, 508
studies were identified in which the relationships between IL-18-137C/G and
-607A/C polymorphism and TB susceptibility could be explored. Finally, six
case-control studies satisfied the preset inclusion standards.[12-17] The characteristics of all
the studies are shown in Tables 1 and 2.
Figure 1.
Flow diagram of included/excluded studies.
Table 1.
Included studies of the IL-18 -137C/G polymorphism with tuberculosis.
Included studies of the IL-18 -607A/C polymorphism with tuberculosis.
Polymorphism (cases/controls)
First author
Yr
Country
Ethnicity
Cases/controls
CC
CA
AA
HWE test
Harishankar
2007
India
Asian
165/173
75/85
71/73
19/15
0.90
Liang
2009
China
Asian
200/195
51/60
110/92
39/43
0.49
Han
2011
China
Asian
296/680
45/164
168/395
83/121
0.00
Lee
2011
Korea
Asian
240/225
62/54
113/116
65/55
0.64
Taheri
2012
Iran
Asian
174/177
74/68
80/90
20/19
0.18
Zhou
2015
China
Asian
407/469
109/124
217/247
81/98
0.22
HWE: Hardy–Weinberg equilibrium
Flow diagram of included/excluded studies.Included studies of the IL-18-137C/G polymorphism with tuberculosis.TB: tuberculosis; HWE: Hardy–Weinberg equilibrium.Included studies of the IL-18-607A/C polymorphism with tuberculosis.HWE: Hardy–Weinberg equilibrium
Results of meta-analysis
For the IL-18-137C/G polymorphism, a total of 970 patients and 1775 controls
were identified. No association between -137C/G polymorphism and the
susceptibility to TB was found (GG vs. AA: OR = 0.71, 95% CI 0.43–1.17; GA vs.
AA: OR = 0.80, 95% CI 0.57–1.13; dominant model: OR = 0.78, 95% CI 0.56–1.08;
recessive model: OR = 0.76, 95% CI 0.46–1.25; Table 3). For the IL-18-607A/C
polymorphism, a total of 813 patients and 990 controls were considered. The
combined results indicated that the -607A/C polymorphism did not result in a
higher TB risk (AA vs. CC: OR = 1.25, 95% CI 0.87–1.79; CA vs. CC: OR = 1.10,
95% CI 0.93–1.29; dominant model: OR = 1.13, 95% CI 0.90–1.41; recessive model:
OR = 1.17, 95% CI 0.90–1.53; Table 4). Furthermore, a subgroup
analysis was performed, and when the non-HWE studies were eliminated, the
results did not change, indicating statistical significance of the meta-analysis
results (Figures 2 and
3). A sensitivity
analysis was performed by assessing the influence of each individual paper on
the combined OR via deleting one study at a time (Figures 4 and 5). There was no single article that
influenced the combined ORs, suggesting that the results are stable.
Table 3.
Summary ORs and 95% CI of the IL-18 -137C/G polymorphism with
tuberculosis risk.
Variables
N
[a]
GG vs. AA
GA vs. AA
Dominant model
Recessive model
OR (95% CI)
model
OR (95% CI)
model
OR (95% CI)
model
OR (95% CI)
model
Total
4
0.71 (0.43–1.17)
F
0.80 (0.57–1.13)
R
0.78 (0.56–1.08)
R
0.76 (0.46–1.25)
F
HWE
Yes
3
0.71 (0.39–1.29)
F
0.87 (0.56–1.34)
R
0.85 (0.56–1.29)
R
0.75 (0.41–1.36)
F
No
1
0.72 (0.29–1.78)
/
0.64 (0.39–1.03)
/
0.59 (0.38–0.92)
/
0.80 (0.32–1.97)
/
aNumber of comparisons.
OR: odds ratio; CI: confidence interval.
Table 4.
Summary ORs and 95% CI of the IL-18 -607A/C polymorphism with
tuberculosis risk.
Variables
N
[a]
AA vs. CC
CA vs. CC
Dominant model
Recessive model
OR (95% CI)
model
OR (95% CI)
model
OR (95% CI)
model
OR (95% CI)
model
Total
6
1.25 (0.87–1.79)
R
1.10 (0.93-1.29)
F
1.13 (0.90–1.41)
R
1.17 (0.90–1.53)
R
HWE
Yes
5
1.03 (0.81–1.31)
R
1.01 (0.84–1.21)
F
1.01 (0.85–1.21)
R
1.02 (0.83–1.25)
R
No
1
2.50 (1.62–3.85)
/
1.55 (1.06–2.26)
/
1.77 (1.23–2.55)
/
1.80 (1.31–2.48)
/
aNumber of comparisons.
Figure 2.
Forest plot for meta-analysis of the association between the IL-18
-137C/G polymorphism and tuberculosis (TB) risk under GG versus AA.
Figure 3.
Forest plot for meta-analysis of the association between the IL-18
-607A/C polymorphism and TB risk under AA versus CC.
Figure 4.
Subgroup analysis for meta-analysis of the association between the IL-18
-137C/G polymorphism and TB risk under GG versus AA.
Figure 5.
Subgroup analysis for meta-analysis of the association between the IL-18
-607A/C polymorphism and TB risk under AA versus CC.
Forest plot for meta-analysis of the association between the IL-18-137C/G polymorphism and tuberculosis (TB) risk under GG versus AA.Forest plot for meta-analysis of the association between the IL-18-607A/C polymorphism and TB risk under AA versus CC.Subgroup analysis for meta-analysis of the association between the IL-18-137C/G polymorphism and TB risk under GG versus AA.Subgroup analysis for meta-analysis of the association between the IL-18-607A/C polymorphism and TB risk under AA versus CC.Summary ORs and 95% CI of the IL-18-137C/G polymorphism with
tuberculosis risk.aNumber of comparisons.OR: odds ratio; CI: confidence interval.Summary ORs and 95% CI of the IL-18-607A/C polymorphism with
tuberculosis risk.aNumber of comparisons.
Publication bias
Potential publication bias among the enrolled studies was explored using Begg’s
test, and the results showed no potential publication bias (Figures 6 and 7).
Figure 6.
Begg’s funnel plot analysis to detect potential publication bias for
IL-18 -137C/G polymorphism under GG versus AA.
Figure 7.
Begg’s funnel plot analysis to detect potential publication bias for
IL-18 -607A/C polymorphism under AA versus CC.
Begg’s funnel plot analysis to detect potential publication bias for
IL-18-137C/G polymorphism under GG versus AA.Begg’s funnel plot analysis to detect potential publication bias for
IL-18-607A/C polymorphism under AA versus CC.
Discussion
TB, one of the major infectious diseases, is still a leading public-health problem
and a main cause of morbidity and mortality worldwide. Despite thorough
investigation, the causes are not yet fully understood. Numerous existing studies
have demonstrated that the IL-18-137C/G and -607A/C polymorphisms are associated
with TB. However, no consistent results have been obtained. Therefore, the current
meta-analysis was performed to extract data from the related published or
unpublished studies. Independent study results were synthesised using statistical
methods by the identical research target, so as to acquire a combined quantitative
conclusion. Typically, the current meta-analysis aimed to integrate similar studies
to enlarge the sample size as well as the statistical power, thus obtaining more
authentic results.This meta-analysis aimed to detect an association of -137C/G and -607A/C
polymorphisms of the IL-18 gene with the susceptibility to TB by including all
qualifying data. To the best of our knowledge, the current meta-analysis is the
first to investigate the relationships between IL-18 polymorphisms and TB. The
results revealed that IL-18-137C/G and -607A/C polymorphisms were not associated
with susceptibility to TB. Probably, the non-HWE studies were associated with
potential selection bias or genotyping errors, thereby leading to misleading
findings. Furthermore, subgroup analysis was also be carried out to remove studies
with a genotype distribution that deviated from HWE in the control group, and no
altered results were detected, indicating the result of the meta-analysis was
statistically significant.These findings suggest that the risk of TB may be not related to IL-18-137C/G and
-607A/C polymorphisms, or that so far, research has been insufficient to identify
such an association. There are several potential explanations for the negative
results. First, given that multiple genes are related to susceptibility to TB, the
focus should be on interactions between genes. Typically, the IL-18-607A/C
polymorphism was found may synergistically increase the risk of TB with rs5744247
and rs549908, and a previous study showed that these haplotypes (including -607A/C,
rs5744247 and rs549908) in the IL-18 gene may synergistically increase the
susceptibility to TB.[16] Second, the findings may also be related to the heterogeneity among the
studies included in the current analysis. Heterogeneity can be derived from any
variation in terms of genetic constitution and/or environmental trait among
different populations, as well as the various sample selection criteria (such as
age, sex and diagnostic criteria) and the varying study designs.[18] Third, the data from the studies included in the present meta-analysis were
mainly from Asian subjects. Other ethnicities, including Caucasian, Africans and
others, should be investigated in future studies. Finally, the effect of
gene–environment interactions was not addressed due to a lack of relevant data.Taken together, this meta-analysis indicates that the -137C/G and -607A/C
polymorphisms of the IL-18 gene are not related to susceptibility to TB. Further
studies are needed to clarify these findings and to address the limitations of the
current research.
Authors: Masoud Dara; Colleen D Acosta; Natalie V S Vinkeles Melchers; Haider A A Al-Darraji; Dato Chorgoliani; Hernan Reyes; Rosella Centis; Giovanni Sotgiu; Lia D'Ambrosio; Sarabjit S Chadha; Giovanni Battista Migliori Journal: Int J Infect Dis Date: 2015-03 Impact factor: 3.623
Authors: Adam Kretowski; Katarzyna Mironczuk; Anna Karpinska; Urszula Bojaryn; Maciej Kinalski; Zbigniew Puchalski; Ida Kinalska Journal: Diabetes Date: 2002-11 Impact factor: 9.461
Authors: Jason R Andrews; Farzad Noubary; Rochelle P Walensky; Rodrigo Cerda; Elena Losina; C Robert Horsburgh Journal: Clin Infect Dis Date: 2012-01-19 Impact factor: 9.079